Anna Elizabeth Rutherford, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Failure, Acute | 5 | 2012 | 175 | 1.640 |
Why?
|
Keratin-18 | 2 | 2012 | 40 | 0.930 |
Why?
|
Peripartum Period | 1 | 2018 | 111 | 0.640 |
Why?
|
Hepatolenticular Degeneration | 1 | 2016 | 76 | 0.590 |
Why?
|
Fanconi Syndrome | 1 | 2016 | 38 | 0.590 |
Why?
|
Abdominal Pain | 1 | 2016 | 1026 | 0.370 |
Why?
|
Peptide Fragments | 2 | 2012 | 5111 | 0.370 |
Why?
|
Liver | 3 | 2021 | 7594 | 0.370 |
Why?
|
Hepatitis B, Chronic | 3 | 2019 | 345 | 0.350 |
Why?
|
Liver Transplantation | 4 | 2016 | 2019 | 0.350 |
Why?
|
Liver Regeneration | 1 | 2008 | 221 | 0.300 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15909 | 0.290 |
Why?
|
Hepatocyte Growth Factor | 1 | 2007 | 291 | 0.290 |
Why?
|
Bile Duct Diseases | 1 | 2006 | 99 | 0.280 |
Why?
|
End Stage Liver Disease | 2 | 2021 | 263 | 0.240 |
Why?
|
Fontan Procedure | 2 | 2020 | 740 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3959 | 0.240 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2019 | 2034 | 0.230 |
Why?
|
Liver Diseases | 1 | 2011 | 1243 | 0.230 |
Why?
|
Spleen | 2 | 2021 | 2463 | 0.220 |
Why?
|
Clinical Competence | 1 | 2018 | 4630 | 0.220 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2019 | 1323 | 0.210 |
Why?
|
Hepatocytes | 1 | 2008 | 1238 | 0.200 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4455 | 0.200 |
Why?
|
Physicians | 1 | 2018 | 4375 | 0.200 |
Why?
|
Ascites | 2 | 2020 | 341 | 0.190 |
Why?
|
Antidepressive Agents | 1 | 2011 | 2827 | 0.170 |
Why?
|
Dermatofibrosarcoma | 1 | 2018 | 60 | 0.170 |
Why?
|
Paracentesis | 1 | 2018 | 94 | 0.170 |
Why?
|
Liver Cirrhosis | 3 | 2021 | 1757 | 0.170 |
Why?
|
Interleukin-6 | 1 | 2007 | 3171 | 0.160 |
Why?
|
Facial Transplantation | 1 | 2020 | 217 | 0.160 |
Why?
|
Trientine | 1 | 2016 | 11 | 0.160 |
Why?
|
Ceruloplasmin | 1 | 2016 | 56 | 0.150 |
Why?
|
Transaminases | 1 | 2016 | 209 | 0.140 |
Why?
|
Gallbladder | 1 | 2016 | 297 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3542 | 0.130 |
Why?
|
Chelating Agents | 1 | 2016 | 401 | 0.130 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.130 |
Why?
|
Apoptosis | 2 | 2008 | 9973 | 0.130 |
Why?
|
Peritonitis | 1 | 2016 | 378 | 0.120 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 4272 | 0.120 |
Why?
|
Copper | 1 | 2016 | 380 | 0.120 |
Why?
|
Hepatitis B | 1 | 2018 | 650 | 0.120 |
Why?
|
Area Under Curve | 2 | 2021 | 1687 | 0.120 |
Why?
|
Methotrexate | 1 | 2020 | 1725 | 0.120 |
Why?
|
Postnatal Care | 1 | 2014 | 230 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 2937 | 0.110 |
Why?
|
Prenatal Care | 1 | 2019 | 1040 | 0.110 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1005 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2021 | 2091 | 0.110 |
Why?
|
Waiting Lists | 1 | 2016 | 714 | 0.100 |
Why?
|
Depression | 1 | 2011 | 7268 | 0.100 |
Why?
|
Bilirubin | 1 | 2012 | 390 | 0.100 |
Why?
|
International Normalized Ratio | 1 | 2012 | 369 | 0.100 |
Why?
|
Aftercare | 1 | 2016 | 718 | 0.100 |
Why?
|
Massachusetts | 3 | 2018 | 8743 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2016 | 800 | 0.100 |
Why?
|
Postpartum Period | 1 | 2016 | 990 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1363 | 0.090 |
Why?
|
Coma | 1 | 2012 | 381 | 0.090 |
Why?
|
Body Mass Index | 1 | 2006 | 12535 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5463 | 0.090 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4103 | 0.080 |
Why?
|
Female | 17 | 2021 | 377204 | 0.080 |
Why?
|
Hemodynamics | 1 | 2018 | 4214 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2018 | 3451 | 0.080 |
Why?
|
Pregnancy | 5 | 2019 | 27398 | 0.080 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 228 | 0.080 |
Why?
|
Celiac Disease | 1 | 2015 | 762 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2016 | 1425 | 0.080 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 209 | 0.080 |
Why?
|
Adult | 12 | 2021 | 212266 | 0.080 |
Why?
|
Iron | 1 | 2015 | 1735 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2016 | 1744 | 0.070 |
Why?
|
Pilot Projects | 2 | 2011 | 8075 | 0.070 |
Why?
|
Skin | 1 | 2020 | 4298 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2950 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 619 | 0.070 |
Why?
|
Humans | 22 | 2021 | 715777 | 0.070 |
Why?
|
ROC Curve | 1 | 2012 | 3524 | 0.060 |
Why?
|
Biopsy | 1 | 2016 | 6736 | 0.060 |
Why?
|
Bile Acids and Salts | 1 | 2006 | 355 | 0.060 |
Why?
|
Obesity | 1 | 2006 | 12248 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13618 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2016 | 2802 | 0.060 |
Why?
|
Necrosis | 1 | 2008 | 1645 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9004 | 0.060 |
Why?
|
Pruritus | 1 | 2006 | 333 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2011 | 800 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39300 | 0.060 |
Why?
|
Ultrasonography | 1 | 2016 | 5922 | 0.060 |
Why?
|
Prognosis | 4 | 2021 | 29005 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2006 | 570 | 0.060 |
Why?
|
Male | 12 | 2021 | 350324 | 0.060 |
Why?
|
Biological Transport | 1 | 2006 | 2121 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4140 | 0.050 |
Why?
|
Middle Aged | 9 | 2021 | 214639 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2103 | 0.050 |
Why?
|
Graft Survival | 1 | 2011 | 3750 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3947 | 0.050 |
Why?
|
Young Adult | 3 | 2016 | 56226 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5318 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2021 | 72443 | 0.050 |
Why?
|
Odds Ratio | 1 | 2012 | 9984 | 0.050 |
Why?
|
Survival Analysis | 1 | 2012 | 10499 | 0.040 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2000 | 215 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9377 | 0.040 |
Why?
|
Graft Rejection | 1 | 2011 | 4396 | 0.040 |
Why?
|
Patient Readmission | 1 | 2011 | 2980 | 0.040 |
Why?
|
Risk Factors | 4 | 2016 | 70866 | 0.040 |
Why?
|
X Chromosome | 1 | 2000 | 820 | 0.040 |
Why?
|
Osteoporosis | 1 | 2006 | 1567 | 0.040 |
Why?
|
Eye Proteins | 1 | 2000 | 655 | 0.040 |
Why?
|
Comorbidity | 1 | 2011 | 10435 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15199 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12456 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2007 | 11689 | 0.030 |
Why?
|
Aged | 5 | 2021 | 162448 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 293 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1735 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2012 | 58323 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 14438 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2020 | 892 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1546 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 34430 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 697 | 0.030 |
Why?
|
Desensitization, Immunologic | 1 | 2018 | 485 | 0.030 |
Why?
|
Macular Degeneration | 1 | 2000 | 941 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7895 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2843 | 0.030 |
Why?
|
Adolescent | 2 | 2012 | 85155 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1842 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12480 | 0.030 |
Why?
|
Age Factors | 2 | 2019 | 18784 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 51315 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 23464 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2016 | 62004 | 0.020 |
Why?
|
Gastroenterology | 1 | 2014 | 513 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40875 | 0.020 |
Why?
|
Incidence | 1 | 2006 | 20731 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4194 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 11945 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6552 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 11201 | 0.020 |
Why?
|
United States | 2 | 2019 | 67905 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23729 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2789 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2548 | 0.020 |
Why?
|
Prevalence | 1 | 2019 | 14911 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10284 | 0.010 |
Why?
|
Mutation | 1 | 2006 | 29291 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 13758 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 11721 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7446 | 0.010 |
Why?
|
Primary Health Care | 1 | 2014 | 4522 | 0.010 |
Why?
|
Retinoblastoma | 1 | 2000 | 315 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21797 | 0.010 |
Why?
|
Animals | 2 | 2006 | 169420 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13626 | 0.010 |
Why?
|
Cattle | 1 | 2000 | 3958 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 5061 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40029 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6484 | 0.010 |
Why?
|
Retina | 1 | 2000 | 2631 | 0.010 |
Why?
|
Gene Expression | 1 | 2000 | 7954 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2000 | 9504 | 0.000 |
Why?
|
Mice | 1 | 2000 | 80375 | 0.000 |
Why?
|